Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$1.3 million.

  • Icu Medical's Exchange Rate Effect fell 11835.31% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 11217.36%. This contributed to the annual value of -$4.9 million for FY2024, which is 25583.31% down from last year.
  • Icu Medical's Exchange Rate Effect amounted to -$1.3 million in Q3 2025, which was down 11835.31% from $6.7 million recorded in Q2 2025.
  • Icu Medical's 5-year Exchange Rate Effect high stood at $7.0 million for Q3 2024, and its period low was -$9.4 million during Q4 2024.
  • For the 5-year period, Icu Medical's Exchange Rate Effect averaged around -$324052.6, with its median value being -$1.1 million (2021).
  • Per our database at Business Quant, Icu Medical's Exchange Rate Effect crashed by 71964.29% in 2022 and then surged by 172409.64% in 2024.
  • Quarter analysis of 5 years shows Icu Medical's Exchange Rate Effect stood at -$1.1 million in 2021, then skyrocketed by 194.33% to $999000.0 in 2022, then soared by 326.43% to $4.3 million in 2023, then crashed by 320.68% to -$9.4 million in 2024, then soared by 86.32% to -$1.3 million in 2025.
  • Its Exchange Rate Effect stands at -$1.3 million for Q3 2025, versus $6.7 million for Q2 2025 and $3.0 million for Q1 2025.